BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26367347)

  • 1. SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.
    Gautrey H; Jackson C; Dittrich AL; Browell D; Lennard T; Tyson-Capper A
    RNA Biol; 2015; 12(10):1139-51. PubMed ID: 26367347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How is Herstatin, a tumor suppressor splice variant of the oncogene HER2, regulated?
    Silipo M; Gautrey H; Satam S; Lennard T; Tyson-Capper A
    RNA Biol; 2017 May; 14(5):536-543. PubMed ID: 27935425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
    Xu L; Shen J; Jia J; Jia R
    Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.
    Ajiro M; Tang S; Doorbar J; Zheng ZM
    J Virol; 2016 Oct; 90(20):9138-52. PubMed ID: 27489271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hnRNP H1 and intronic G runs in the splicing control of the human rpL3 gene.
    Russo A; Siciliano G; Catillo M; Giangrande C; Amoresano A; Pucci P; Pietropaolo C; Russo G
    Biochim Biophys Acta; 2010; 1799(5-6):419-28. PubMed ID: 20100605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress-inducible truncated serine/arginine-rich splicing factor 3 regulates interleukin-8 production in human colon cancer cells.
    Kano S; Nishida K; Kurebe H; Nishiyama C; Kita K; Akaike Y; Kajita K; Kurokawa K; Masuda K; Kuwano Y; Tanahashi T; Rokutan K
    Am J Physiol Cell Physiol; 2014 Feb; 306(3):C250-62. PubMed ID: 24284797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells.
    Chen X; Yang HT; Zhang B; Phillips JW; Cheng D; Rigo F; Witte ON; Xing Y; Black DL
    Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2220190120. PubMed ID: 37399401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Analysis of Heterogeneous Nuclear Ribonucleoprotein (hnRNP) Binding to HIV-1 RNA Reveals a Key Role for hnRNP H1 in Alternative Viral mRNA Splicing.
    Kutluay SB; Emery A; Penumutchu SR; Townsend D; Tenneti K; Madison MK; Stukenbroeker AM; Powell C; Jannain D; Tolbert BS; Swanstrom RI; Bieniasz PD
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2.
    DeLigio JT; Stevens SC; Nazario-Muñoz GS; MacKnight HP; Doe KK; Chalfant CE; Park MA
    Mol Cancer Res; 2019 Sep; 17(9):1920-1930. PubMed ID: 31138601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
    Talukdar I; Sen S; Urbano R; Thompson J; Yates JR; Webster NJ
    PLoS One; 2011; 6(11):e27869. PubMed ID: 22132154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair.
    He X; Zhang P
    Mol Cancer; 2015 Aug; 14():158. PubMed ID: 26282282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive regulation of alternative splicing and alternative polyadenylation by hnRNP H and CstF64 determines acetylcholinesterase isoforms.
    Nazim M; Masuda A; Rahman MA; Nasrin F; Takeda JI; Ohe K; Ohkawara B; Ito M; Ohno K
    Nucleic Acids Res; 2017 Feb; 45(3):1455-1468. PubMed ID: 28180311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
    Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
    Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Mcl-1 alternative splicing by hnRNP F, H1 and K in breast cancer cells.
    Tyson-Capper A; Gautrey H
    RNA Biol; 2018; 15(12):1448-1457. PubMed ID: 30468106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
    Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
    Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.
    Jia R; Ajiro M; Yu L; McCoy P; Zheng ZM
    RNA; 2019 May; 25(5):630-644. PubMed ID: 30796096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exon 9 skipping of apoptotic caspase-2 pre-mRNA is promoted by SRSF3 through interaction with exon 8.
    Jang HN; Lee M; Loh TJ; Choi SW; Oh HK; Moon H; Cho S; Hong SE; Kim DH; Sheng Z; Green MR; Park D; Zheng X; Shen H
    Biochim Biophys Acta; 2014 Jan; 1839(1):25-32. PubMed ID: 24321384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells.
    Jia R; Zhang S; Liu M; Zhang Y; Liu Y; Fan M; Guo J
    Sci Rep; 2016 Nov; 6():35976. PubMed ID: 27808105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
    Yang S; Jia R; Bian Z
    Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIN28A Modulates Splicing and Gene Expression Programs in Breast Cancer Cells.
    Yang J; Bennett BD; Luo S; Inoue K; Grimm SA; Schroth GP; Bushel PR; Kinyamu HK; Archer TK
    Mol Cell Biol; 2015 Sep; 35(18):3225-43. PubMed ID: 26149387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.